Vitamin D 2 — Competitive Intelligence Brief

Vitamin D 2 (Vitamin D 2) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog. Area: Endocrinology.

phase 3 Vitamin D analog Vitamin D receptor Endocrinology Small molecule

Target snapshot

Vitamin D 2 (Vitamin D 2) — Department of Medical Services Ministry of Public Health of Thailand. Vitamin D 2 is a form of vitamin D that plays a crucial role in calcium absorption and bone health.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin D 2 TARGET	Vitamin D 2	Department of Medical Services Ministry of Public Health of Thailand	phase 3	Vitamin D analog	Vitamin D receptor
FOSAMAX PLUS D	FOSAMAX PLUS D	Organon and Co	marketed	Bisphosphonate + vitamin D3 combination	Osteoclast proton pump (alendronate); vitamin D receptor (cholecalciferol)
D3 vitamin	D3 vitamin	Medical University of Lodz	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Taclonex Topical Suspension	Taclonex Topical Suspension	University of Pittsburgh	marketed	Combination topical agent (vitamin D analog + corticosteroid)	Vitamin D receptor (VDR) and glucocorticoid receptor (GR)
FOSAMAX PLUS	FOSAMAX PLUS	Organon and Co	marketed	Bisphosphonate with vitamin D3 supplement	Osteoclast farnesyl pyrophosphate synthase (alendronate); vitamin D receptor (cholecalciferol)
Paricalcitol: Zemplar®	Paricalcitol: Zemplar®	Hospital Universitario de Canarias	marketed	Vitamin D receptor agonist	Vitamin D receptor (VDR)
calcipotriene + clobetasol propionate	calcipotriene + clobetasol propionate	Leon Kircik, M.D.	marketed	Topical combination therapy (vitamin D analog + corticosteroid)	Vitamin D receptor (VDR) and glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analog class)

1. LEO Pharma · 2 drugs in this class
2. Genzyme, a Sanofi Company · 2 drugs in this class
3. National Cancer Institute, Naples · 2 drugs in this class
4. OPKO Health, Inc. · 2 drugs in this class
5. Joslin Diabetes Center · 1 drug in this class
6. Kyowa Kirin, Inc. · 1 drug in this class
7. Maimónides Biomedical Research Institute of Córdoba · 1 drug in this class
8. Shanghai Jiao Tong University Affiliated Sixth People's Hospital · 1 drug in this class
9. Shiraz University of Medical Sciences · 1 drug in this class
10. St. Justine's Hospital · 1 drug in this class